RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+31.11%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$3.42B
AUM Growth
+$3.42B
(+37%)
Cap. Flow
+$357M
Cap. Flow
% of AUM
10.46%
Top 10 Holdings %
Top 10 Hldgs %
45.63%
Holding
88
New
10
Increased
35
Reduced
24
Closed
6
Top Buys
| 1 |
Amicus Therapeutics
FOLD
|
$154M |
| 2 |
CELG
Celgene Corp
CELG
|
$50.5M |
| 3 |
Align Technology
ALGN
|
$40.7M |
| 4 |
Biogen
BIIB
|
$39.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
$35.5M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$134M |
| 2 |
Cigna
CI
|
$44.1M |
| 3 |
Medtronic
MDT
|
$38.2M |
| 4 |
CVS Health
CVS
|
$25.1M |
| 5 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$20.7M |
Sector Composition
| 1 | Healthcare | 94.57% |
| 2 | Financials | 2.23% |
| 3 | Energy | 0.01% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
1
DELISTED
Array Biopharma Inc
ARRY
| $267M | 7.83% | 10,970,518 -5,488,610 | -33% | -$134M |
|
|
2
Amicus Therapeutics
FOLD
$2.34B
| $267M | 7.81% | 19,616,062 +11,292,845 | +136% | +$154M |
|
3
Fate Therapeutics
FATE
$120M
| $182M | 5.33% | 10,359,666 | – | – |
|
4
Atara Biotherapeutics
ATRA
$84.6M
| $178M | 5.22% | 4,485,417 +70,800 | +2% | +$2.81M |
|
5
argenx
ARGX
$43.6B
| $127M | 3.72% | 1,019,061 +58,100 | +6% | +$7.25M |
|
|
CLVS
6
DELISTED
Clovis Oncology, Inc.
CLVS
| $113M | 3.31% | 4,563,929 +503,400 | +12% | +$12.5M |
|
|
ALDR
7
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $113M | 3.29% | 8,244,896 +1,739,130 | +27% | +$23.7M |
|
8
Wave Life Sciences
WVE
$1.53B
| $110M | 3.22% | 2,831,507 +593,900 | +27% | +$23.1M |
|
|
BOLD
9
DELISTED
Audentes Therapeutics, Inc
BOLD
| $107M | 3.12% | 2,735,267 +433,600 | +19% | +$16.9M |
|
|
EPZM
10
DELISTED
Epizyme, Inc
EPZM
| $95.3M | 2.79% | 7,694,020 +1,056,742 | +16% | +$13.1M |
|
11
Xencor
XNCR
$580M
| $94.3M | 2.76% | 3,036,603 -48,100 | -2% | -$1.49M |
|
|
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
| $90.4M | 2.64% | 2,874,100 +336,800 | +13% | +$10.6M |
|
13
InflaRx
IFRX
$108M
| $82.5M | 2.41% | 2,182,638 +147,238 | +7% | +$5.56M |
|
14
Regenxbio
RGNX
$451M
| $81.4M | 2.38% | 1,420,342 +65,600 | +5% | +$3.76M |
|
15
uniQure
QURE
$896M
| $78M | 2.28% | 1,307,522 +4,100 | +0.3% | +$245K |
|
|
16
Bristol-Myers Squibb
BMY
$96B
| $76.3M | 2.23% | 1,599,700 +745,000 | +87% | +$35.5M |
|
17
eHealth
EHTH
$118M
| $76.2M | 2.23% | 1,222,405 +131,010 | +12% | +$8.17M |
|
|
ALLK
18
DELISTED
Allakos
ALLK
| $74.3M | 2.17% | 1,834,410 +135,762 | +8% | +$5.5M |
|
19
LivaNova
LIVN
$3.08B
| $56.7M | 1.66% | 582,687 +67,700 | +13% | +$6.58M |
|
20
Tandem Diabetes Care
TNDM
$845M
| $54.4M | 1.59% | 855,932 -183,818 | -18% | -$11.7M |
|
21
Elevance Health
ELV
$71.8B
| $50.7M | 1.48% | 176,700 +61,200 | +53% | +$17.6M |
|
|
CELG
22
DELISTED
Celgene Corp
CELG
| $50.5M | 1.48% | +535,700 | New | +$50.5M |
|
23
Teva Pharmaceuticals
TEVA
$21.1B
| $49.3M | 1.44% | 3,147,000 +1,318,100 | +72% | +$20.7M |
|
24
Penumbra
PEN
$10.6B
| $47.5M | 1.39% | 323,170 +177,562 | +122% | +$26.1M |
|
|
25
Align Technology
ALGN
$10.3B
| $40.7M | 1.19% | +143,200 | New | +$40.7M |
|